Skip to Content



View full screen / Print PDF » Download PDF ⇩
Common Technical Document
Module 1 – Administrative and Prescribing Information
Module 1.3 – Product Information

Ralgex Freeze Spray

Text to appear on the Patient Information Leaflet
Glycol Monosalicylate 10% w/w, Methoxymethane 14.41% w/w and Isopentane 67.77% w/w
Pl ease read this leaflet carefully before using Ralgex Freeze Spray.
• Keep this leaflet, you may wish to read it again.
• Ask your pharmacist if you need more information or advice.
What is this spray used for?
This cutaneous spray solution is used for the symptomatic relief of muscular pain and stiffness,
including backache, sciatica, lumbago, fibrositis, rheumatic pain.
It is also used for the symptomatic relief of sprains, strains and bruises associated with sports
injuries, and stiffness following sporting exercise.
Before using this spray
Do not use…
• If you are allergic to any of the ingredients in this product, in particular salicylates (e.g. aspirin) or
other non‐steroidal anti inflammatory drugs (including pain killers). See ‘What this spray contains'
for the full list of ingredients.
• On broken or inflamed skin.
• If you suffer from poor blood circulation which makes the toes and fingers numb and pale
(Raynaud's disease).
Take special care…
• Some people experience stronger effects with Ralgex Freeze Spray than others. Try on a small
area first.
• Not for use with occlusive dressings.
• Do not spray on the head or neck.
• Avoid inhalation and contact with the eyes.
• Always spray sparingly; over application can cause discomfort.
• Do not spray on sensitive body areas or broken skin or on large areas of body.
• This spray is for external use only.
• Use with caution during pregnancy.
How to use this spray
Adults, the elderly and children 5 years and over:
• Shake well before use. in with the arrow pointing to the site of pain
• Hold the can about 6 inches from the skin.
• Press button to spray 2‐3 short bursts.
• This may be repeated up to 4 times daily
If symptoms persist, consult your doctor.

January 2015 - LB

Common Technical Document
Module 1 – Administrative and Prescribing Information
Module 1.3 – Product Information

Ralgex Freeze Spray

Children under 5 years:
• Not to be used on children under 5 years of age.
If you use too much of this spray…
If you use more of the spray that you should, speak to your doctor or pharmacist.
Possible side effects
As with all medicines this liquid can have side effects in some people.
• Rarely, mild skin irritation has been reported. If you feel you are reacting badly to this medicine in
any way, or notice any other side effects not listed in this leaflet, please tell your doctor or
How to store this spray
• Keep out of the sight and reach of children.
• Caution extremely flammable: Pressurised container. Protect from sunlight and do not expose to
temperatures greater than 50°C. Do not pierce or burn, even after use. Keep away from sources of
ignition. No smoking. Do not spray on a naked flame or incandescent material. Avoid contact with
polished surfaces.
• Do not use after the expiry shown on the can.
• If you find that you still have this medicine after its expiry date, return it to your local pharmacist
who will dispose of it properly.
What this spray contains
Ralgex® Freeze Spray contains 10% by weight of the active ingredient glycol monosalicylate,
14.41% by weight of the active ingredient methoxymethane and 67.77% by weight of the active
ingredient isopentane. Glycol monosalicylate is a topical analgesic and anti‐inflammatory agent
which provides pain relief. The mixture of methoxymethane and isopentane rapidly cools the skin
and numbs it, providing a counter‐irritant effect. It also contains isopropyl alcohol and menthol.
The spray comes in aerosols containing either 125 or 150ml.
Marketing Authorisation Holder:
G R Lane Health Products Ltd. Sisson Road, Gloucester, GL2 0GR, UK.
Manufactured by: ColepCCL Rapid‐Spray & Co. KG Fockestrasse 12, 88471 Laupheim, Germany
Date of revision: July 2013.
Ralgex is a trade mark of the SSL Group.

January 2015 - LB

Expand view ⇕

Source: Medicines and Healthcare Products Regulatory Agency

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.